Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Am J Manag Care. 2014 Nov;20(11):e498–e505.

Table 5.

Probability of Having a Heart-Disease Related Readmission Conditional on Medication Adherence, Using Bayesian Probability Theory

Prob. (Good Adherence | No Readmission) Prob. (Good Adherence | Readmission) Prob. (Readmission | Good Adherence)a Prob. (Readmission | Bad Adherence)a
First Readmission Occurring During 6-9 Months Post-MI Discharge
MPR >=0.75 for All MI Drugs 0.569 0.510 0.086 0.107
MPR >=0.75 for β-Blockers 0.661 0.619 0.090 0.106
MPR >=0.80 for All MI Drugs 0.507 0.446 0.085 0.106
MPR >=0.80 for β-Blockers 0.634 0.593 0.089 0.105
First Readmission Occurring During 9-12 Months Post-MI Discharge
MPR >=0.75 for All MI Drugs 0.578 0.505 0.071 0.093
MPR >=0.75 for β-Blockers 0.694 0.646 0.075 0.092
MPR >=0.80 for All MI Drugs 0.522 0.442 0.069 0.092
MPR >=0.80 for β-Blockers 0.674 0.621 0.075 0.092
a

The probability of having a readmission conditional on whether one was a good adherent or not was calculated using Bayes' rule